Literature DB >> 23440386

Altered expression of PTCH and HHIP in gastric cancer through their gene promoter methylation: novel targets for gastric cancer.

Yu Song1, Ye Tian, Yun Zuo, Jian-Cheng Tu, Yu-Fang Feng, Chen-Jiang Qu.   

Abstract

Human hedgehog-interacting protein (HHIP) and protein patched homolog (PTCH) are two negative regulators of the hedgehog signal, however, the mechanism of action in gastric cancer is unknown. Methylation of TSG promoters has been considered as a causative mechanism of tumorigenesis. In the present study, we first determined the expression of PTCH and HHIP mRNA and protein in gastric cancer tissues and adjacent normal tissues, and then detected methylation of the two genes to associate their expression and gene promoter methylation in gastric cancer. Expression in gastric cancer tissues and the cancer cells (AGS) were evaluated by reverse transcription-PCR (RT-PCR), qRT-PCR and IHC, while the methylation expression was valued by methylation-specific PCR (MSP) and bisulfite sequencing PCR (BSP). Cell viability and apoptosis were analyzed by MTT assay and flow cytometry following treatment with 5-aza-dc. Results showed that PTCH and HHIP expression was reduced in gastric cancer tissues that were not associated with clinical features. Moreover, methylation of the promoters was reversely correlated with the expression. Following treatment with 5-aza-dc, AGS reduced cell viability and induced apoptosis, which is associated with upregulation of HHIP expression. The data demonstrated that loss of expression of HHIP and PTCH is associated with the methylation of gene promoters. In addition, 5-aza-dc-induced apoptosis correlated with the upregulation of HHIP expression in AGS. The findings demonstrated that the PTCH and HHIP genes may be novel targets for the control of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23440386     DOI: 10.3892/mmr.2013.1333

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

1.  Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells.

Authors:  Peichao Li; Xiaoru Zhang; Anthony J Murphy; Max Costa; Xiaogang Zhao; Hong Sun
Journal:  Carcinogenesis       Date:  2021-02-11       Impact factor: 4.944

2.  The hedgehog antagonist HHIP as a favorable prognosticator in glioblastoma.

Authors:  Liang Chang; Ping Zhang; Dan Zhao; Huibin Liu; Qiushi Wang; Chenlong Li; Wenzhong Du; Xing Liu; Haitao Zhang; Zhiren Zhang; Chuanlu Jiang
Journal:  Tumour Biol       Date:  2015-10-19

Review 3.  Hedgehog pathway aberrations and gastric cancer; evaluation of prognostic impact and exploration of therapeutic potentials.

Authors:  Omar Abdel-Rahman
Journal:  Tumour Biol       Date:  2015-02-14

Review 4.  Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy.

Authors:  Silvia Pandolfi; Barbara Stecca
Journal:  Expert Rev Mol Med       Date:  2015-02-09       Impact factor: 5.600

5.  Hedgehog pathway maintains cell survival under stress conditions, and drives drug resistance in lung adenocarcinoma.

Authors:  Erh-Hsuan Lin; Yu-Rung Kao; Chih-An Lin; Ting-Yu Kuo; Sheng-Ping Yang; Chiung-Fang Hsu; Teh-Ying Chou; Chao-Chi Ho; Cheng-Wen Wu
Journal:  Oncotarget       Date:  2016-04-26

6.  Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.

Authors:  Jarosław Paluszczak; Dorota Wiśniewska; Magdalena Kostrzewska-Poczekaj; Katarzyna Kiwerska; Reidar Grénman; Daniela Mielcarek-Kuchta; Małgorzata Jarmuż-Szymczak
Journal:  Clin Oral Investig       Date:  2016-08-23       Impact factor: 3.573

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.